Protective role of growth hormone against hyperhomocysteinemia-induced glomerular injury

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 386, Issue 6, 2013, Pages 551-561

  Li, Caixia ^a   Xia, Min ^a   Abais, Justine M ^a   Liu, Xiaocheng ^b   Li, Ningjun ^a   Boini, Krishna M ^a   Li, Pin Lan ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

EMT; End stage renal disease; Growth hormone; Homocysteine

Indexed keywords

ALBUMIN; ALPHA SMOOTH MUSCLE ACTIN; CALVASCULIN; GROWTH HORMONE; GROWTH HORMONE RECEPTOR; HOMOCYSTEINE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; P CADHERIN; RECOMBINANT GROWTH HORMONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SUPEROXIDE;

ANIMAL EXPERIMENT; ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIAPHRAGM; ENZYME ACTIVATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GLOMERULONEPHRITIS; GROWTH HORMONE BLOOD LEVEL; HYPERHOMOCYSTEINEMIA; KIDNEY CORTEX; MOUSE; NONHUMAN; PODOCYTE; PROTEIN EXPRESSION; PROTEINURIA; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; WESTERN BLOTTING;

ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH HORMONE; HYPERHOMOCYSTEINEMIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY GLOMERULUS; MALE; MICE; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; PODOCYTES; REACTIVE OXYGEN SPECIES; REAL-TIME POLYMERASE CHAIN REACTION; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SUPEROXIDES;

EID: 84878017175     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-013-0848-1     Document Type: Article

References (52)

1. Arnold RE, Weigent DA (2003) The inhibition of superoxide production in EL4 lymphoma cells overexpressing growth hormone. Immunopharmacol Immunotoxicol 25:159-177
2. Boini KM, Xia M, Li C, Zhang C, Payne LP, Abais JM, Poklis JL, Hylemon PB, Li PL (2011a) Acid sphingomyelinase gene deficiency ameliorates the hyperhomocysteinemia-induced glomerular injury in mice. Am J Pathol 179(5):2210-2219
3. Boini KM, Xia M, Xiong J, Li C, Payne LP, Li PL (2011b) Implication of CD38 gene in podocyte epithelial-to-mesenchymal transition and glomerular sclerosis. J Cell Mol Med 6(8):1674-1685
4. Boini KM, Zhang C, Xia M, Poklis JL, Li PL (2010) Role of sphingolipid mediator ceramide in obesity and renal injury in mice fed a high-fat diet. J Pharmacol Exp Ther 334:839-846
5. Chen YF, Li PL, Zou AP (2002) Effect of hyperhomocysteinemia on plasma or tissue adenosine levels and renal function. Circulation 106:1275-1281
6. Csiszar A, Labinskyy N, Perez V, Recchia FA, Podlutsky A, Mukhopadhyay P, Losonczy G, Pacher P, Austad SN, Bartke A, Ungvari Z (2008) Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. Am J Physiol Heart Circ Physiol 295:H1882-H1894
7. Deng L, Jiang J, Frank SJ (2012) Growth hormone-induced JAK2 signaling and GH receptor down-regulation: role of GH receptor intracellular domain tyrosine residues. Endocrinology 153(5):2311-2322
8. Dressler GR (2006) The cellular basis of kidney development. Annu Rev Cell Dev Biol 22:509-529
9. Erman A, Wabitsch M, Goodyer CG (2011) Human growth hormone receptor (GHR) expression in obesity: II. Regulation of the human GHR gene by obesity-related factors. Int J Obes (Lond) 35:1520-1529
10. Feneberg R, Schaefer F, Veldhuis JD (2003) Neuroendocrine adaptations in renal disease. Pediatr Nephrol 18:492-497
11. Francis ME, Eggers PW, Hostetter TH, Briggs JP (2004) Association between serum homocysteine and markers of impaired kidney function in adults in the United States. Kidney Int 66:303-312
12. Griguer CE, Oliva CR, Kelley EE, Giles GI, Lancaster JR Jr, Gillespie GY (2006) Xanthine oxidase-dependent regulation of hypoxia-inducible factor in cancer cells. Cancer Res 66:2257-2263
13. Haase VH (2009) Pathophysiological consequences of HIF activation: HIF as a modulator of fibrosis. Ann N Y Acad Sci 1177:57-65
14. Hedayati N, Annambhotla S, Jiang J, Wang X, Chai H, Lin PH, Yao Q, Chen C (2009) Growth hormone-releasing peptide ghrelin inhibits homocysteine-induced endothelial dysfunction in porcine coronary arteries and human endothelial cells. J Vasc Surg 49:199-207
15. Iacobini C, Menini S, Oddi G, Ricci C, Amadio L, Pricci F, Olivieri A, Sorcini M, Di Mario U, Pesce C, Pugliese G (2004) Galectin-3/AGE-receptor 3 knockout mice show accelerated AGE-induced glomerular injury: evidence for a protective role of galectin-3 as an AGE receptor. FASEB J 18:1773-1775
16. Kang YS, Li Y, Dai C, Kiss LP, Wu C, Liu Y (2010) Inhibition of integrin-linked kinase blocks podocyte epithelial-mesenchymal transition and ameliorates proteinuria. Kidney Int 78:363-373
17. Krieg RJ Jr, Veldhuis JD, Thornhill BA, Chevalier RL, Gil G (2008) Growth hormone (GH) secretion, GH-dependent gene expression, and sexually dimorphic body growth in young rats with chronic renal failure. Endocrine 33:323-330
18. Leeuwis JW, Nguyen TQ, Dendooven A, Kok RJ, Goldschmeding R (2010) Targeting podocyte-associated diseases. Adv Drug Deliv Rev 62:1325-1336
19. Lewandowski KC, Murray RD, Drzewoski J, O'Callaghan CJ, Czupryniak L, Hillhouse EW, Shalet SM, Randeva HS (2003) Plasma total homocysteine concentrations in adults with growth hormone (GH) deficiency: effects of GH replacement. Mol Genet Metab 80:330-337
20. Li CX, Xia M, Han WQ, Li XX, Zhang C, Boini KM, Liu XC, Li PL (2011) Reversal by growth hormone of homocysteine-induced epithelial-to-mesenchymal transition through membrane raft-redox signaling in podocytes. Cell Physiol Biochem 27:691-702
21. Li N, Yi F, Sundy CM, Chen L, Hilliker ML, Donley DK, Muldoon DB, Li PL (2007) Expression and actions of HIF prolyl-4-hydroxylase in the rat kidneys. Am J Physiol Renal Physiol 292:F207-F216
22. Liu Y (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21:212-222
23. Mak RH, Cheung WW, Roberts CT Jr (2008) The growth hormone-insulin-like growth factor-I axis in chronic kidney disease. Growth Horm IGF Res 18:17-25
24. Moshal KS, Singh M, Sen U, Rosenberger DS, Henderson B, Tyagi N, Zhang H, Tyagi SC (2006) Homocysteine-mediated activation and mitochondrial translocation of calpain regulates MMP-9 in MVEC. Am J Physiol Heart Circ Physiol 291:H2825-H2835
25. Nangaku M (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17:17-25
26. Nangaku M, Fujita T (2008) Activation of the renin-angiotensin system and chronic hypoxia of the kidney. Hypertens Res 31:175-184
27. Pfeifer M, Verhovec R, Zizek B, Prezelj J, Poredos P, Clayton RN (1999) Growth hormone (GH) treatment reverses early atherosclerotic changes in GH-deficient adults. J Clin Endocrinol Metab 84:453-457
28. Rabkin R, Awwad I, Chen Y, Ashley EA, Sun D, Sood S, Clusin W, Heidenreich P, Piecha G, Gross ML (2008) Low-dose growth hormone is cardioprotective in uremia. J Am Soc Nephrol 19:1774-1783
29. Randeva HS (2003) Hormonal regulation of homocysteine. Metab Syndr Relat Disord 1:121-128
30. Ravaglia G, Forti P, Maioli F, Martelli M, Servadei L, Brunetti N, Porcellini E, Licastro F (2005) Homocysteine and folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82:636-643
31. Sabanayagam C, Shankar A (2010) Association between plasma homocysteine and microalbuminuria in persons without hypertension, diabetes mellitus, and cardiovascular disease. Clin Exp Nephrol 15(1):92-99
32. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K (2005) Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 293:1082-1088
33. Seiva FR, Ebaid GM, Castro AV, Okoshi K, Nascimento A, Rocha KK, Padovani CR, Cicogna AC, Novelli EL (2008) Growth hormone and heart failure: oxidative stress and energetic metabolism in rats. Growth Horm IGF Res 18:275-283
34. Sen U, Basu P, Abe OA, Givvimani S, Tyagi N, Metreveli N, Shah KS, Passmore JC, Tyagi SC (2009) Hydrogen sulfide ameliorates hyperhomocysteinemia- associated chronic renal failure. Am J Physiol Renal Physiol 297:F410-F419
35. Sesmilo G, Biller BM, Llevadot J, Hayden D, Hanson G, Rifai N, Klibanski A (2001) Effects of growth hormone (GH) administration on homocyst(e)ine levels in men with GH deficiency: a randomized controlled trial. J Clin Endocrinol Metab 86:1518-1524
36. Sun S, Ning X, Zhang Y, Lu Y, Nie Y, Han S, Liu L, Du R, Xia L, He L, Fan D (2009) Hypoxia-inducible factor-1alpha induces Twist expression in tubular epithelial cells subjected to hypoxia, leading to epithelial-to-mesenchymal transition. Kidney Int 75:1278-1287
37. Triantafyllou N, Evangelopoulos ME, Kimiskidis VK, Kararizou E, Boufidou F, Fountoulakis KN, Siamouli M, Nikolaou C, Sfagos C, Vlaikidis N, Vassilopoulos D (2008) Increased plasma homocysteine levels in patients with multiple sclerosis and depression. Ann Gen Psychiatry 7:17
38. Ungvari Z, Gautam T, Koncz P, Henthorn JC, Pinto JT, Ballabh P, Yan H, Mitschelen M, Farley J, Sonntag WE, Csiszar A (2010) Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf rats. J Gerontol A Biol Sci Med Sci 65:1145-1156
39. Vakili H, Jin Y, Cattini PA (2012) Negative regulation of human growth hormone gene expression by insulin is dependent on hypoxia-inducible factor binding in primary non-tumor pituitary cells. J Biol Chem 287(40):33282-33292
40. Wang Z, Tang L, Zhu Q, Yi F, Zhang F, Li PL, Li N (2011) Hypoxia-inducible factor-1alpha contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int 79:300-310
41. Wu CH, Tang SC, Wang PH, Lee H, Ko JL (2012) Nickel-induced epithelial-mesenchymal transition by reactive oxygen species generation and E-cadherin promoter hypermethylation. J Biol Chem 287:25292-25302
42. Wuhl E, Schaefer F (2002) Effects of growth hormone in patients with chronic renal failure: experience in children and adults. Horm Res 58(Suppl 3):35-38
43. Yang MH, Wu KJ (2008) TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle 7:2090-2096
44. Yang MH, Wu MZ, Chiou SH, Chen PM, Chang SY, Liu CJ, Teng SC, Wu KJ (2008) Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol 10:295-305
45. Yi F, Jin S, Zhang F, Xia M, Bao JX, Hu J, Poklis JL, Li PL (2009a) Formation of lipid raft redox signalling platforms in glomerular endothelial cells: an early event of homocysteine-induced glomerular injury. J Cell Mol Med 13:3303-3314
46. Yi F, Xia M, Li N, Zhang C, Tang L, Li PL (2009b) Contribution of guanine nucleotide exchange factor Vav2 to hyperhomocysteinemic glomerulosclerosis in rats. Hypertension 53:90-96
47. Zhang C, Hu JJ, Xia M, Boini KM, Brimson C, Li PL (2010a) Redox signaling via lipid raft clustering in homocysteine-induced injury of podocytes. Biochim Biophys Acta 1803:482-491
48. Zhang C, Hu JJ, Xia M, Boini KM, Brimson CA, Laperle LA, Li PL (2010b) Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91(phox) gene. Free Radic Biol Med 48(8):1109-1117
49. Zhang C, Hu JJ, Xia M, Boini KM, Brimson CA, Laperle LA, Li PL (2010c) Protection of podocytes from hyperhomocysteinemia-induced injury by deletion of the gp91phox gene. Free Radic Biol Med 48:1109-1117
50. Zhang C, Xia M, Boini KM, Li CX, Abais JM, Li XX, Laperle LA, Li PL (2011) Epithelial-to-mesenchymal transition in podocytes mediated by activation of NADPH oxidase in hyperhomocysteinemia. Pflugers Arch 462:455-467
51. Zhang T, Qu H, Li X, Zhao B, Zhou J, Li Q, Sun M (2010d) Transmembrane delivery and biological effect of human growth hormone via a phage displayed peptide in vivo and in vitro. J Pharm Sci 99:4880-4891
52. Zhu Q, Wang Z, Xia M, Li PL, Van Tassell BW, Abbate A, Dhaduk R, Li N (2011) Silencing of hypoxia-inducible factor-1alpha gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension 58:657-664